Cancer Drug Supplier's IPO Mints Tuam Tshoj tus Billionaire Tseeb

Hnub no cov npe ntawm Shanghai Tshuag Txauv los ntawm Sichuan Biokin Pharmaceutical, tus neeg muag khoom ntawm cov tshuaj qog noj ntshav, tau minted Tuam Tshoj tus billionaire tshiab kawg.

Thawj Tswj Hwm Zhu Yi ncaj qha muaj 298.1 lab shares, muaj nqis 10 billion yuan, los yog $ 1.5 billion nyob rau yav tsaus ntuj trading. Shares tau nce 36% los ntawm lawv tus nqi IPO rau 33.69 yuan.

Zhu tau kawm tiav qib siab hauv xov tooj cua technology, nrog rau kev kawm tiav qib siab hauv biology los ntawm Fudan University thiab tus kws kho mob hauv kev tswj hwm kev tshawb fawb los ntawm Sichuan University. Nws qhia immunology thiab microbiology ntawm West China Medical University hauv 1991-92.

Zhu nrhiav tau Biokin hauv xyoo 1996. Nws ua haujlwm hauv Tebchaws Meskas los ntawm Redmond, Washington-based subsidiary, Systimmune. Tuam Tshoj kev ruaj ntseg tswj hwm tau pom zoo Biokin's IPO thaum Lub Kaum Ob Hlis.

Lub teb chaws thiab Teb Chaws Asmeskas qeb thib 1 thiab No. 2 ntawm cov neeg mob qog noj ntshav thiab tag nrho cov mob qog noj ntshav. Tuam Tshoj yog lub tsev rau lub ntiaj teb thib ob tus lej ntawm billionaires tom qab Tebchaws Meskas.

Saib lwm cov posts:

Teb Chaws Asmeskas, Tuam Tshoj ua ntej kev sib tham kom nrawm rau kev sim tshuaj tua kab mob

Tuam Tshoj tus nplua nuj tshaj plaws Saib Cov Ntaub Ntawv Plunge In Wealth

Cov lus nug tshiab tshwm sim rau Asmeskas kev lag luam hauv Suav teb tom qab "Jarring" Xaus Rau Zero-Covid Txoj Cai

@rflannerychina